Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning.
Iwasaki M, Kanda J, Arai Y, Kondo T, Ishikawa T, Ueda Y, Imada K, Akasaka T, Yonezawa A, Yago K, Nohgawa M, Anzai N, Moriguchi T, Kitano T, Itoh M, Arima N, Takeoka T, Watanabe M, Hirata H, Asagoe K, Miyatsuka I, An LM, Miyanishi M, Takaori-Kondo A.
Iwasaki M, et al. Among authors: anzai n.
Blood Adv. 2022 Apr 26;6(8):2618-2627. doi: 10.1182/bloodadvances.2021005800.
Blood Adv. 2022.
PMID: 34933327
Free PMC article.